Presentations & Publications

We are proud of our scientific progress, much of which has been documented via various presentations and publications.

Since 2011, our proprietary platform has enabled the design of three new clinical drug candidates, resulting in four clinical programs. Our scientific progress has been documented in various national and international presentations and publications.

April 2012

Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles

Advancing Promising Therapies